Priya Mittal

Dr. Priya Mittal

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Nature Reviews Clinical Oncology
Verified
Journal Article
Closed access
PDF file
PMPriya Mittal
Priya Mittal
CRCharles W. M. Roberts
Charles W. M. Roberts

20 July 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
PMPriya Mittal
Priya Mittal
YSYong-Hyun Shin
Yong-Hyun Shin
SYSvetlana A. Yatsenko
Svetlana A. Yatsenko
CCCarlos A. Castro
Carlos A. Castro
USUrvashi Surti
Urvashi Surti
ARAleksandar Rajkovic
Aleksandar Rajkovic
Uterine leiomyomas are benign tumors that can cause pain, bleeding, and infertility in some women. Mediator complex subunit 12 (MED12) exon 2 variants are associated with uterine leiomyomas; however, the causality of MED12 variants, their genetic mode of action, and their role in genomic instability have not been established. Here, we generated a mouse model that conditionally expresses a Med12 missense variant (c.131G>A) in the uterus and demonstrated that this alteration alone promotes uterine leiomyoma formation and hyperplasia in both WT mice and animals harboring a uterine mesenchymal cell–specific Med12 deletion. Compared with WT animals, expression of Med12 c.131G>A in conditional Med12–KO mice resulted in earlier onset of leiomyoma lesions that were also greater in size. Moreover, leiomyomatous, Med12 c.131G>A variant–expressing uteri developed chromosomal rearrangements. Together, our results show that the common human leiomyoma–associated MED12 variant can cause leiomyomas in mice via a gain of function that drives genomic instability, which is frequently observed in human leiomyomas.

1 February 2017 in Fertility and Sterility
Verified
Journal Article
Closed access
SYSvetlana A. Yatsenko
Svetlana A. Yatsenko
PMPriya Mittal
Priya Mittal
MWMichelle A. Wood-Trageser
Michelle A. Wood-Trageser
MJMirka W. Jones
Mirka W. Jones
USUrvashi Surti
Urvashi Surti
ARAleksandar Rajkovic
Aleksandar Rajkovic

22 May 2024 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
PMPriya Mittal
Priya Mittal
GJGanesh R Jadhav
Ganesh R Jadhav
MPMansing Pawar
Mansing Pawar
SBSitikantha Banerjee
Sitikantha Banerjee
SWSneha Wangaskar
Sneha Wangaskar
Giuseppe MinerviniGiuseppe Minervini
Giuseppe Minervini
Background: Self-assessment (SA) is an interactive course that endorses the accomplishment of learning objectives through learners’ identification of insufficiencies in their didactic knowledge and pre-clinical skills. This study was planned to determine whether there is any improvement in the faculty assessment (FA) score following the implementation of SA in the Pre-clinical Conservative Dentistry Course. Methods: Fifty-four first-semester dental students were given an introductory lecture followed by a demonstration for Class I Cavity Preparation in typhodont mandibular first molar. At the end of the demonstration, the Scoring Rubric (SR) was explained point-wise in the prepared cavities. During the next session, all students performed Class I cavity preparation and they were given an assessment sheet to enter their scores (SA1). All teeth were evaluated by the Grading Faculties in a blinded manner (FA1). Each participant was explained the difference in their respective SA1 from FA1 and their queries were resolved individually. During the next sessions, Students and Grading Faculties followed the same protocol and scores were recorded as SA2, FA2, SA3 and FA3. Results: The mean score of SA1 was significantly higher than that of FA1 (p < 0.001). However, no significant difference was obtained between SA and FA in the second (p = 0.352) and third (p = 0.434) assessments. In contrast with first assessment, mean marks obtained in FA were higher compared to SA in both second and third assessments. There was a statistically significant improvement in mean marks obtained by the students over time (p < 0.001). Conclusion: SA endorsed student-faculty communication and enhanced student’s poise and technical skills in operative pre-clinical dentistry.

8 November 2017 in Biology of Reproduction
Verified
Journal Article
Closed access
PDF file
XWXinye Wang
Xinye Wang
PMPriya Mittal
Priya Mittal
CCCarlos A Castro
Carlos A Castro
GRGabriel Rajkovic
Gabriel Rajkovic
ARAleksandar Rajkovic
Aleksandar Rajkovic
The transcriptional factor MED12 is part of the essential mediator transcriptional complex that acts as a transcriptional coactivator in all eukaryotes. Missense gain of function mutations in human MED12 are associated with uterine leiomyomas, yet the role of MED12 deficiency in tumorigenesis and reproductive biology has not been fully explored. We generated a Med12 reproductive conditional knockout mouse model to evaluate its role in uterine mesenchyme, granulosa cells, and oocytes. Mice heterozygous for Med12 deficiency in granulosa cells and uterus (Med12fl/+ Amhr2-Cre) were subfertile, while mice homozygous for Med12 deficiency in granulosa cells and uterus (Med12fl/fl Amhr2-Cre) were infertile. Morphological and histological analysis of the Med12fl/fl Amhr2-Cre reproductive tract revealed atrophic uteri and hyperchromatic granulosa cells with disrupted expression of Lhcgr, Esr1, and Esr2. Med12fl/fl Amhr2-Cre mice estrous cycle was disrupted and serum analysis showed blunted rise in estradiol in response to PMSG. Uterine atrophy was partially rescued by exogenous steroid supplementation with dysregulation of Notch1 and Smo expression in steroid supplemented Med12fl/fl Amhr2-Cre uteri, indicating intrinsic uterine defects. Oocyte specific ablation of Med12 caused infertility without disrupting normal folliculogenesis and ovulation, consistent with maternal effects of Med12 in early embryo development. These results show the critical importance of Med12 in reproductive tract development and that Med12 loss of function does not cause tumorigenesis in reproductive tissues.

7 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAngelica Barreto-Galvez
Angelica Barreto-Galvez
MNMrunmai Niljikar
Mrunmai Niljikar
JGJulia Elizabeth Gagliardi
Julia Elizabeth Gagliardi
CGCarolina Plasencia Guzman
Carolina Plasencia Guzman
RZRanran Zhang
Ranran Zhang
AMAdvaitha Madireddy
Advaitha Madireddy
Mutations in the global transcriptional activator EP300/KAT3B are being reported in aggressive malignancies. However, the mechanistic contribution of EP300 dysregulation to cancer is currently unknown. While EP300 has been implicated in regulating cell cycle and DNA replication, the role of EP300 in maintaining replication fork integrity has not been studied. Here, using EP300-mutated adult T-cell leukemia/lymphoma cells and an EP300-selective degrader, we reveal that EP300 loss leads to pronounced dysregulations in DNA replication dynamics and persistent genomic instability. Aberrant DNA replication in EP300-mutated cells is characterized by elevated replication origin firing due to replisome pausing. EP300 deficiency results in a prominent defect in fork protection resulting in the accumulation of single-stranded DNA gaps. Importantly, we find that the loss of EP300 results in decreased expression of BRCA2 protein leading to sensitivity to treatments that are cytotoxic to BRCA-deficient cancers. Overall, we demonstrate that EP300-mutated cells recapitulate features of BRCA-deficient cancers.